U.S. DOJ accepting applications for a Comprehensive Opioid Abuse Site-based Grant Program
Monday, February 13, 2017
Posted by: Jessica Austin
The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Assistance (BJA) is seeking applications to plan and implement comprehensive strategies in response to the growing opioid epidemic. This program furthers the Department’s mission by providing resources to state, local, and tribal governments to intervene with persons with substance use disorders.
Comprehensive Opioid Abuse Site-based Program FY 2017 Competitive Grant Announcement Applications Due: April 25, 2017
Eligible applicants are those that meet the following criteria for the six following categories:
Category 1: Overdose Outreach Projects – Applicants are limited to units of local government and federally recognized Indian tribal governments (as determined by the Secretary of the Interior).
Category 2: Technology-assisted Treatment Projects – Applicants are limited to state agencies. State agencies include state administrative offices, state criminal justice agencies, and other state agencies involved with the provision of substance use disorder services to justice-involved individuals such as the State Administering Agency (SAA), the Administrative Office of the Courts, and the State Alcohol and Substance Abuse Agency.
Category 3: System-level Diversion and Alternatives to Incarceration Projects – Applicants are limited to units of local government and federally recognized Indian tribal governments (as determined by the Secretary of the Interior).
Category 4: Statewide Planning, Coordination, and Implementation Projects – Applicants are limited to the State Administering Agency (SAA) responsible for directing criminal justice planning or the State Alcohol and Substance Abuse Agency.
Category 5: Harold Rogers Prescription Drug Monitoring Program (PDMP) Implementation and Enhancement Projects – Applicants are limited to state governments that have a pending or enacted enabling statute or regulation requiring the submission of controlled substance prescription data to an authorized state agency. Applicants within a state that does not have an enabling state statute requiring the submission of controlled substance prescription data to an authorized state agency are eligible to apply as a city, county, or region if (a) the city, county, or region has enacted an enabling statute, ordinance, or regulation requiring the submission of controlled substance prescription data to an authorized city, county, or region and (b) the city, county, or region agrees to transition the PDMP system to an authorized state 2 BJA-2017- 11447 agency when and if the state adopts an enabling state statute requiring the submission of controlled substance prescription data to an authorized state agency and ensures that all vendor contracts are written to permit the transfer of ownership of the system to the authorized state agency.
Category 6: Data-driven Responses to Prescription Drug Misuse – Applicants are limited to state agencies and units of local government located in states with existing and operational prescription drug monitoring programs and federally recognized Indian tribal governments (as determined by the Secretary of the Interior).
For any of the categories listed above, BJA welcomes applications under which two or more entities would carry out the goals of the federal award; however, only one entity may be the authorized representative listed on the application. Any others must be proposed as subrecipients (“subgrantees"). The authorized representative must be the entity that would have primary responsibility for carrying out the award, including administering the funding and managing the entire project. Other entities may, however, be proposed as subrecipients (“subgrantees”) in more than one application. This includes applications that propose to serve a region that crosses state boundaries. Subrecepients may include treatment providers and other not-for-profit entities as part of a comprehensive cross-disciplinary response as outlined in Categories 1–4 and Category 6.
An agency should submit only one application per category. If an agency wishes to apply under multiple categories, a separate application is needed for each category of funding.
NOTE: In addition to this announcement, in FY 2017, BJA is offering stand-alone solicitations for Drug Courts and Veterans Treatment Courts, Residential Substance Abuse Treatment, Smart Policing, Smart Prosecution, and Second Chance Act reentry initiatives. These solicitations may be relevant to potential applicants seeking to implement specific drug-related strategies. Eligible applicants are encouraged to review these other solicitations as they are released. The stand-alone Harold Rogers Prescription Drug Monitoring grant program has been incorporated into the FY 2017 Comprehensive Opioid Abuse Site-based Program solicitation as Categories 5 and 6 of funding. For more information on BJA’s current solicitations, visit the following link: https://www.bja.gov.
BJA may also elect to fund applications submitted under this FY 2017 solicitation in future fiscal years, dependent on, among other considerations, the merit of the applications and on the availability of appropriations.
Applicants must register with Grants.gov prior to submitting an application. All applications are due by 11:59 p.m. eastern time on April 25, 2017.
Click here to access the full funding opportunity announcement